WELLS FARGO & COMPANY/MN - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$138
-9.8%
35
+2.9%
0.00%
Q2 2023$153
-11.6%
34
+6.2%
0.00%
Q1 2023$173
+10.2%
320.0%0.00%
Q4 2022$15732
+6.7%
0.00%
Q3 2022$030
-9.1%
0.00%
Q2 2022$033
+10.0%
0.00%
Q1 2022$0300.0%0.00%
Q4 2021$0
-100.0%
30
-89.5%
0.00%
Q3 2021$2,000287
+744.1%
0.00%
Q2 2021$0340.0%0.00%
Q1 2021$0
-100.0%
34
-98.6%
0.00%
Q4 2020$13,000
-70.5%
2,432
-75.7%
0.00%
Q3 2020$44,000
-44.3%
10,004
-30.1%
0.00%
Q2 2020$79,000
-21.8%
14,314
-14.5%
0.00%
Q1 2020$101,000
-41.6%
16,745
-11.8%
0.00%
Q4 2019$173,000
-21.7%
18,980
-22.0%
0.00%
Q3 2019$221,000
-4.7%
24,345
+6.2%
0.00%
Q2 2019$232,000
+74.4%
22,924
+140.6%
0.00%
Q1 2019$133,000
+54.7%
9,526
+74.9%
0.00%
Q4 2018$86,000
-11.3%
5,445
+5.6%
0.00%
Q3 2018$97,000
-26.0%
5,154
-24.2%
0.00%
Q2 2018$131,000
-12.1%
6,800
-2.4%
0.00%
Q1 2018$149,000
+3.5%
6,967
-0.6%
0.00%
Q4 2017$144,000
+161.8%
7,008
+136.1%
0.00%
Q3 2017$55,000
+120.0%
2,968
+196.5%
0.00%
Q2 2017$25,000
-16.7%
1,001
-33.3%
0.00%
Q1 2017$30,0001,5010.00%
Q4 2016$000.00%
Q3 2016$00
-100.0%
0.00%
Q2 2016$010.0%0.00%
Q1 2016$010.00%
Q4 2015$00
-100.0%
0.00%
Q3 2015$0
-100.0%
1
-100.0%
0.00%
Q2 2015$318,000
+5.3%
21,442
+17.7%
0.00%
Q1 2015$302,00018,2220.00%
Q4 2014$000.00%
Q3 2014$0
-100.0%
0
-100.0%
0.00%
Q2 2014$26,000
-13.3%
1,805
+2.7%
0.00%
Q1 2014$30,0001,7580.00%
Q4 2013$00
-100.0%
0.00%
Q3 2013$010.0%0.00%
Q2 2013$010.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 40,001$276,0000.13%
SANTA MONICA PARTNERS LP 20,000$138,0000.10%
Invenomic Capital Management LP 135,631$769,0000.08%
Cannell Capital 78,306$540,0000.08%
RBF Capital, LLC 144,231$996,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 266,502$1,839,0000.04%
Ancora Advisors LLC 80,728$557,0000.01%
HighMark Wealth Management LLC 2,039$14,0000.01%
Renaissance Technologies 341,422$2,356,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 34,618$240,0000.00%
View complete list of PSYCHEMEDICS CORP shareholders